fig3
![<i>Bifidobacterium</i> and the intestinal mucus layer](https://image.oaes.cc/33bc28b6-e62b-4251-9974-fa3b9fbdc93e/mrr2037.fig.3.jpg)
Figure 3. Diagram outlining the major beneficial effects, especially in improving goblet cell function and in reducing inflammation, per Bifidobacterium species in disease models. GABA: B. dentium-generated gamma-aminobutyric acid; NEC: necrotizing enterocolitis; SCFAs: short-chain fatty acids.